Materialise has announced the latest edition of its Mimics Innovation Suite including Mimics 18.0 and 3-matic 10.0 software solutions.
The improved version reduces segmentation time and makes design and modelling even more realistic. A host of new features means visualisation capabilities have been expanded to offer fluoroscopy view and virtual X-ray simulation and it’s now possible to 3D print the results in full colour.
The Mimics suite offers a comprehensive toolset for biomedical professionals and the addition of a ‘Fluoroscopy View’ tool enables simulation of the angiographic view that healthcare specialists would experience during surgery.
A new visualisation option, the ‘Virtual X-ray’ tool has been introduced to allow engineers to create virtual X-rays of projects to find the best angle for registration and allow for the evaluation o the 3D position of bones and implants without post operative scans.
The automated ‘Heart-Segmentation’ tool is a flexible user friendly tool that allows for simple segmentation of 3D heart models for research and analysis. Using a good quality dataset, the software has been updated so that users now only have to make a few mouse clicks to segment the model.
Export options have also been advanced so that a logo can be added to the design within seconds and then exported in *zpr format for 3D printing in colour. In addition to various software improvements, a new way of characterising the mitral valve has been added to the Mimics Innovation Suite. This patent pending workflow allows for a detailed analysis of complex anatomy and reduced the number of design iterations need to qualify for use in clinical trials.
Last week TCT spoke to Materialise Managing Director for the U.S., Bryan Crutchfield, at RAPID about the latest software. “This particular version is more about the accuracy of the data,” Bryan explained. “Part of the need in the industry for 3D printing and medical right now is the ability to prove that its better; that the outcomes are better, that its cheaper, so we’ve started to concentrate on some tools that will allow the clinician or researcher to prove that yes it is better, cheaper, faster.”
